Relay Therapeutics Inc is trading 4.4% up at $15.71 with no clear, stock-specific news catalyst identified so far.
- The move comes amid relatively quiet company headlines and mixed broader markets, suggesting the gain may reflect normal volatility or incremental buying interest.
- Analysts suggest the price action may also represent ongoing rebound momentum following recent declines rather than a defined event like earnings, M&A, or major clinical news.